CRYOPORT, INC. Gain (Loss) on Disposition of Intangible Assets
CRYOPORT, INC. (CYRX) reported Gain (Loss) on Disposition of Intangible Assets of -$17.05 thousand for the 12-month period ending 2013-03-31, per its 10-K filed 2014-06-25.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfIntangibleAssets · last filed 2014-06-25
- CRYOPORT, INC. gain (loss) on disposition of intangible assets for fiscal 2013 was -$17.05K.
- CRYOPORT, INC. gain (loss) on disposition of intangible assets for fiscal 2012 was $0.00.
| Period end | Gain (Loss) on Disposition of Intangible Assets 12 month |
|---|---|
| 2013-03-31 | -$17.05K 10-K · filed 2014-06-25 |
| 2012-03-31 | $0.00 10-K · filed 2013-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |